SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000014272-21-000152
Filing Date
2021-06-15
Accepted
2021-06-15 17:14:41
Documents
3
Period of Report
2021-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162379161729960.html 3  
1 FORM 3 wf-form3_162379161729960.xml 3 1728
2 POWER OF ATTORNEY, WEESE_GRAPHIC weese_poaxnotarizedxfull001.jpg GRAPHIC 163925
3 POWER OF ATTORNEY, WEESE weese_poaxnotarizedxfull.htm EX-24 663
  Complete submission text file 0000014272-21-000152.txt   229759
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Issuer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address
Weese Michelle (Reporting) CIK: 0001867715 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-01136 | Film No.: 211019557